Abercrombie & Fitch Co. vs Bristol-Myers Squibb Co — how do they compare? Abercrombie & Fitch Co. trades at $119.22 (market cap $5.24B), while Bristol-Myers Squibb Co trades at $63.61 (market cap $129.94B). The key difference: Bristol-Myers Squibb Co is far larger — about 24.8× Abercrombie & Fitch Co.'s market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Abercrombie & Fitch Co. pays none. Which is the better fit depends on your goals.
| ANF | BMY | |
|---|---|---|
Market Cap | $5.24B | $129.94B |
Sector | Consumer Cyclical | Health |
52-Week High | $129.85 | $65.89 |
52-Week Low | $65.61 | $42.60 |
Enterprise Value | $5.91B | $163.92B |
Dividend Yield | — | 3.96% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Bristol Myers Squibb (BMY) trades at $64.84, up 0.19% today, with a bullish technical signal from moving averages and strong fundamental health evidenced by a 14.01 P/E ratio and 18.87% net income margin. Recent earnings beats and a $2.3 billion manufacturing investment in Houston highlight operational strength, while analyst consensus is mixed with a $68.56 price target.
The outlook is positive due to earnings momentum and strategic investments, but risks include patent expirations and high debt levels. Wall Street sentiment is cautiously optimistic, with institutional buying supporting the stock's potential for moderate upside from current levels.
Trailing returns across standard periods
Latest headlines on both assets
Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumer through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.
Read more on ANF →Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →